We are live on ! Find out more
IIM

Ipswich Investment Management Portfolio holdings

AUM $474M
1-Year Est. Return 35.58%
This Fund
S&P 500
This Quarter Est. Return
+0.42%
1 Year Est. Return
+35.58%
3 Year Est. Return
+92.81%
5 Year Est. Return
+126.14%
10 Year Est. Return
+1,334%
AUM
$237M
AUM Growth
+$835K
Cap. Flow
+$2.75M
Cap. Flow %
1.16%
Top 10 Hldgs %
28.75%
Holding
156
New
6
Increased
56
Reduced
50
Closed
5

Top Buys

Rank Stock Value
1
DEO icon
Diageo
DEO
+$2.66M
2
ACN icon
Accenture
ACN
+$2.39M
3
CRSP icon
CRISPR Therapeutics
CRSP
+$364K
4
DHR icon
Danaher
DHR
+$253K
5
SQM icon
Sociedad Química y Minera de Chile
SQM
+$223K

Top Sells

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$1.53M
2
CAT icon
Caterpillar
CAT
+$930K
3
POT
Potash Corp Of Saskatchewan
POT
+$344K
4
AMZN icon
Amazon
AMZN
+$336K
5
NFG icon
National Fuel Gas
NFG
+$280K

Sector Composition

Rank Sector Weight
1 Healthcare 17.42%
2 Technology 16.77%
3 Energy 12.57%
4 Financials 12.45%
5 Industrials 11.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNS icon
26
Scotiabank
BNS
$108B
$2.88M 1.21%
46,641
+2,420
+5% +$153K
MRK icon
27
Merck
MRK
$322B
$2.63M 1.11%
50,636
+188
+0.4% +$10.2K
CRSP icon
28
CRISPR Therapeutics
CRSP
$5.16B
$2.61M 1.1%
57,075
+8,818
+18% +$364K
DEO icon
29
Diageo
DEO
$52.8B
$2.59M 1.09%
+19,118
New +$2.66M
PG icon
30
Procter & Gamble
PG
$336B
$2.54M 1.07%
32,074
+995
+3% +$83K
MRSH
31
Marsh
MRSH
$91.6B
$2.41M 1.02%
29,155
+1,620
+6% +$134K
LH icon
32
Labcorp
LH
$26.1B
$2.39M 1.01%
17,195
+210
+1% +$30.8K
CHD icon
33
Church & Dwight Co
CHD
$24.3B
$2.38M 1%
47,200
+684
+1% +$33.7K
ACN icon
34
Accenture
ACN
$109B
$2.32M 0.98%
+15,090
New +$2.39M
TFC icon
35
Truist Financial
TFC
$63.9B
$2.3M 0.97%
44,266
+506
+1% +$27.3K
ORCL icon
36
Oracle
ORCL
$418B
$2.22M 0.94%
48,512
-560
-1% -$27.8K
PX
37
DELISTED
Praxair Inc
PX
$2.19M 0.93%
15,198
+60
+0.4% +$9.33K
CL icon
38
Colgate-Palmolive
CL
$73.7B
$2.16M 0.91%
30,081
-139
-0.5% -$10K
DUK icon
39
Duke Energy
DUK
$95.8B
$2.12M 0.89%
27,319
+515
+2% +$39.8K
PEP icon
40
PepsiCo
PEP
$188B
$2.03M 0.86%
18,602
-50
-0.3% -$5.69K
NVS icon
41
Novartis
NVS
$295B
$1.93M 0.81%
26,594
+1,609
+6% +$122K
BMY icon
42
Bristol-Myers Squibb
BMY
$130B
$1.88M 0.79%
29,667
+1,050
+4% +$67.5K
T icon
43
AT&T
T
$167B
$1.7M 0.72%
63,228
+1,305
+2% +$36.3K
TMO icon
44
Thermo Fisher Scientific
TMO
$222B
$1.64M 0.69%
7,932
-58
-0.7% -$12.2K
BIIB icon
45
Biogen
BIIB
$30.3B
$1.63M 0.69%
5,951
+15
+0.3% +$4.66K
RCL icon
46
Royal Caribbean
RCL
$81.3B
$1.58M 0.67%
13,454
-440
-3% -$55.6K
AKAM icon
47
Akamai
AKAM
$16.9B
$1.58M 0.67%
22,302
+278
+1% +$18.9K
KO icon
48
Coca-Cola
KO
$373B
$1.57M 0.66%
36,065
+740
+2% +$33.2K
MCD icon
49
McDonald's
MCD
$193B
$1.56M 0.66%
9,982
-1,451
-13% -$239K
TTE icon
50
TotalEnergies
TTE
$196B
$1.45M 0.61%
2,306,568
– –
1
2
3 4 5

Similar funds

KC
Keenan Capital Burlingame, California $474M AUM 2.41% 1-Year Est. Return
PCM
Pamplona Capital Management New York $473M AUM 3.78% 1-Year Est. Return
CCM
CoreView Capital Management Hong Kong $473M AUM 14.25% 1-Year Est. Return
CTWM
Cherry Tree Wealth Management Minnetonka, Minnesota $473M AUM 12.37% 1-Year Est. Return
RCM
Rivermont Capital Management New York $475M AUM 116.05% 1-Year Est. Return
BSI
Bregal Sagemount IV St. Helier $472M AUM
SIA
Sovereign Investment Advisors Phoenix, Arizona $472M AUM 9.63% 1-Year Est. Return
AL4A
Accel Leaders 4 Associates Palo Alto, California $475M AUM 391.52% 1-Year Est. Return

Ipswich Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, Ipswich Investment Management held 156 positions worth $237M, up 0.35% from $236M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Ipswich Investment Management's Q1 2018 filing shows 6 new, 56 increased, 50 reduced and 5 closed positions. Its largest new stake was Diageo: 19,118 shares worth $2.59M. The largest sale was SLB Ltd, an estimated $1.53M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Technology and Energy.

  • Ipswich Investment Management's largest Q1 2018 buy was Diageo: 19,118 shares worth $2.59M.
  • Ipswich Investment Management added most to CRISPR Therapeutics in Q1 2018, an estimated $364K increase.
  • Ipswich Investment Management's biggest Q1 2018 reduction was SLB Ltd, cutting an estimated $1.53M.
  • Ipswich Investment Management fully exited Potash Corp Of Saskatchewan in Q1 2018, selling an estimated $344K.
  • Ipswich Investment Management's ten largest holdings make up 29% of its $237M portfolio in Q1 2018.
  • Ipswich Investment Management opened 6 new positions and closed 5 in Q1 2018.
  • Ipswich Investment Management's portfolio value rose 0.35% quarter-over-quarter to $237M.

Based on Ipswich Investment Management's 13F filing for Q1 2018, filed 12 Apr 2018.